FAculty directory

Back to alphabetical index

Ronald Tallarida, PhD

Professor, Pharmacology

Telephone:  215-707- 3243

Fax:  215-707-7068

Email: ronald.tallarida@temple.edu

Department of Pharmacology

Center for Substance Abuse Research

B.S. Drexel University Philadelphia, PA  1959

 

M.S. Drexel University Philadelphia, PA 1963

 

Ph.D. Temple University Philadelphia, PA 1967

Return to top

Research interests involve combination studies of opioids as well as othe drugs of abuse. In addition, we are interested in synergistic interactions between vasoconstructors. The work involves statisical analysis, experimental design and modeling. Interactions between opioids are measured in behavorial mouse models.

Return to top

Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

19328817. Miller JS, Tallarida RJ, Unterwald EM, Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology 56:8(1116-23)2009 Jun

19126780. Braverman AS, Miller LS, Vegesna AK, Tiwana MI, Tallarida RJ, Ruggieri MR Sr, Quantitation of the contractile response mediated by two receptors: M2 and M3 muscarinic receptor-mediated contractions of human gastroesophageal smooth muscle. J Pharmacol Exp Ther 329:1(218-24)2009 Apr

18371948. Lamarre NS, Tallarida RJ, A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. Eur J Pharmacol 586:1-3(350-1)2008 May 31

18339971. Braverman AS, Tallarida RJ, Ruggieri MR Sr, The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions. J Pharmacol Exp Ther 325:3(954-60)2008 Jun

18256173. Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA, Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther 325:2(567-76)2008 May

17592517. Rawls SM, Tallarida R, Robinson W, Amin M, The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. Br J Pharmacol 151:7(1095-102)2007 Aug

17194800. Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK, Adler MW, A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J Pharmacol Exp Ther 320:3(1127-33)2007 Mar

17141755. Raffa RB, Stagliano GW, Tallarida RJ, Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. Eur J Pharmacol 556:1-3(89-90)2007 Feb 5

17109846. Rawls SM, Tallarida RJ, Zisk J, Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy. Eur J Pharmacol 553:1-3(89-98)2006 Dec 28

17079019. Tallarida RJ, Interactions between drugs and occupied receptors. Pharmacol Ther 113:1(197-209)2007 Jan

17045985. Raffa RB, Tallarida RJ, Modified 'Joyce model' of opioid dependence/withdrawal. Eur J Pharmacol 551:1-3(54-7)2006 Dec 3

17018247. Ding Z, Cowan A, Tallarida R, Rawls SM, Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy. Neurosci Lett 409:1(41-6)2006 Nov 27

16914122. Raffa RB, Stagliano GW, Tallarida RJ, Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain Res 1114:1(31-5)2006 Oct 9

16737694. Raffa RB, Baron DA, Tallarida RJ, Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur J Pharmacol 540:1-3(200-1)2006 Jul 1

16670349. Tallarida RJ, An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319:1(1-7)2006 Oct

16257420. Chen X, McClatchy DB, Geller EB, Tallarida RJ, Adler MW, The dynamic relationship between mu and kappa opioid receptors in body temperature regulation. Life Sci 78:4(329-33)2005 Dec 12

16137704. Rawls SM, Jacobs K, Tallarida RJ, Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. Life Sci 78:7(669-72)2006 Jan 11

15640611. Schulingkamp RJ, Aloyo V, Tallarida RJ, Raffa RB, Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology 74:1(23-30)2005 Apr

15476754. Rawls SM, Baron DA, Gomez T, Jacobs K, Tallarida RJ, Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. Eur J Pharmacol 502:3(271-2)2004 Oct 19

15175417. Grabovsky Y, Tallarida RJ, Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310:3(981-6)2004 Sep

Return to top